Nina Mufti

Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC

Nina Mufti, Anna Erickson, Anne North et al. · Biologicals · 2009 · 66 citations

Medicine, Hematology, Microbiology +9

Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates

Reinhard Henschler, Erhard Seifried, Nina Mufti · Transfusion Medicine and Hemotherapy · 2011 · 65 citations · Full text

Medicine, Hematology, Toxicology +17

Red blood cell concentrates treated with the amustaline (S‐303) pathogen reduction system and stored for 35 days retain post‐transfusion viability: results of a two‐centre study

José A. Cancelas, Jerome L. Gottschall, Neeta Rugg et al. · Vox Sanguinis · 2017 · 45 citations · Full text

Medicine, Hematology, Cell Therapy +16

Stored red blood cell viability is maintained after treatment with a second‐generation S‐303 pathogen inactivation process

José A. Cancelas, Larry J. Dumont, Neeta Rugg et al. · Transfusion · 2011 · 40 citations

Medicine, Hematology, Immunology +17

Red blood cells treated with the amustaline (S‐303) pathogen reduction system: a transfusion study in cardiac surgery

V. Brixner, Katharina Madlener, Markus Müller et al. · Transfusion · 2018 · 40 citations · Full text

Medicine, Hematology, Surgery +17